70962-66-2

70962-66-2 structure

Name: Sparfosic acid trisodium
Chemical Name: Sparfosic acid trisodium
CAS Number: 70962-66-2
Molecular Formula: C₆H₇NNa₃O₈P
Molecular Weight: 321.06
Catalog: Research Areas Cancer
Create Date: 2020-04-13 18:51:23
Modify Date: 2024-01-24 19:28:02
Sparfosic acid trisodium, is a potent inhibitor of aspartate transcarbamoyl transferase, with anti-tumor and antimetabolite activity. Aspartate transcarbamoyl transferase catalyzes the second step of de novo pyrimidine biosynthesis[1][2].

Name	Sparfosic acid trisodium

Description	Sparfosic acid trisodium, is a potent inhibitor of aspartate transcarbamoyl transferase, with anti-tumor and antimetabolite activity. Aspartate transcarbamoyl transferase catalyzes the second step of de novo pyrimidine biosynthesis[1][2].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Others >> Others Research Areas >> Metabolic Disease
In Vitro	Sparfosic acid (PALA) treatment causes apoptosis in the resistant Br1 cells[1]. Sparfosic acid (PALA, 300 µM) shows progressive accumulation of cells in S phase and activation of an apoptotic pathway leading to cell death[1]. Cell Cycle Analysis[1] Cell Line: Br-l and L-2 cell lines established from metastasis in nude mouse injected with the human tumor cell line MDA-MB-435. Concentration: 300 µM. Incubation Time: 12, 24 and 48 h. Result: Cells were predominantly in S phase in both the cell lines, although slightly higher proportion of cells in S phase were noted in L-2 than Brl-3prl cells. Western Blot Analysis[1] Cell Line: Br-l and L-2 cell lines. Concentration: 300 µM. Incubation Time: 4, 10 and 24 h. Result: There was moderate difference in the level of phosphorylated Rb proteins seen in the two cell types. Marked increase in the amount of cyclin A protein was detected in the L-2 cells undergoing apoptosis with the highest level detected at 10 h post-drug treatment. In contrast, there was no increase in the level of cyclin A seen in the Brl-3prl cells. Cyclin E protein was found elevated in the L-2 cells and Brl-3prl cells compared to their respective controls.
References	[1]. Wang J, et al. Elevated cyclin A associated kinase activity promotes sensitivity of metastatic human cancer cells to DNA antimetabolite drug. Int J Oncol. 2015 Aug;47(2):782-90. [2]. Angela D. Morris, et al. A New, Efficient, Two Step Procedure for the Preparation of the Antineoplastic Agent Sparfosic Acid

Molecular Formula	C₆H₇NNa₃O₈P
Molecular Weight	321.06

70962-66-2	51321-79-0
65501-25-9	97928-92-2
10361-89-4	150-38-9
18662-53-8	39478-93-8
114456-61-0	207556-02-3